Copyright
©The Author(s) 2024.
World J Radiol. Jun 28, 2024; 16(6): 139-167
Published online Jun 28, 2024. doi: 10.4329/wjr.v16.i6.139
Published online Jun 28, 2024. doi: 10.4329/wjr.v16.i6.139
WHO-IWGE classification | Surgery | Percutaneous treatment | Drug therapy | Suggested optimal treatment |
CE1 | Yes | Yes | < 5 cm | |
Albendazole | ||||
> 5 cm | ||||
PAIR + Albendazole | ||||
CE2 | Yes | Yes | Yes | Non-PAIR percutaneous treatment + Albendazole |
CE3a | Yes | Yes | < 5 cm | |
Albendazole | ||||
> 5 cm | ||||
PAIR + Albendazole | ||||
CE3b | Yes | Yes | Yes | Non-PAIR percutaneous treatment + Albendazole |
CE4 | Watch and wait | |||
CE5 | Watch and wait |
- Citation: Kahraman G, Haberal KM, Dilek ON. Imaging features and management of focal liver lesions. World J Radiol 2024; 16(6): 139-167
- URL: https://www.wjgnet.com/1949-8470/full/v16/i6/139.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i6.139